Without adequate DDoS protection, cancer treatment facilities and research institutions risk facing significant disruptions. These can include loss of access to medical records, interruptions in communication between healthcare professionals, and delays in clinical trials. Moreover, the reputational damage and potential financial losses can be substantial.
